CURRICULUM VITAE Luigi Cubeddu PERSONAL - College of ...

LUIGI X. CUBEDDU
BOOK CHAPTERS
1. Goldstein, D.J., Finklelman, S., Cubeddu, L.X., Talmaciu, R. and Nahmod, V.E. Angiotensin and DBH in the
cerebrospinal fluid of normotensive and essential hypertensive patients. In: "The central action of angiotensin and
related hormones." (Ed. Buckley & Ferrario) 563, P. Press, 1977.
2. Cubeddu, L.X. Plasma and cerebrospinal fluid dopamine-beta-hydroxylase activity, in animal stress and human
hypertension. In "Catecholamines: basic and clinical frontiers". Vol. 2, p. 1509-1511, 1979.
3. Trifaro, J.M. and Cubeddu, L.X. Exocytosis as the mechanism of noradrenergic transmitter release. In: "Trends in
Autonomic Pharmacology". Vol. l, p. 195-250, Ed. S. Kalsner, Urban & Schwarzenberg, 1979.
4. Cubeddu, L.X. Release of dopamine-beta-hydroxylase from noradrenergic nerve terminals and adrenal medulla:
discrepancy with in vivo plasma measurements. Proc. Third Congress of Hungarian Pharmacol. Soc. 137-138, 1979.
5. Cubeddu, L.X., Hoffmann, I.S. and Paris, V. Effects of phosphodiesterase inhibitors and cyclic AMP on
norepinephrine and dopamine release. In: "Presynaptic Receptors". Ed. Langer et. al. Pergamon Press, Oxford and
New York, p. 311-315, 1980.
6. Cubeddu, L.X. and Goldstein, D.J. Reduced dopamine-beta-hydroxylase activity in the cerebrospinal fluid of
essential hypertensive patients. Perspectives in Cardiovascular Research, Vol. 6, Series Editor A.M. Katz. In:
"Central Nervous System Mechanisms in Hypertension." Ed. J.P. Buckley and C.M. Ferrario. Raven Press, New
York, p. 153-159, 1981.
7. Viveros, O.H., Wilson, S.P., Cubeddu, L.X. and Kirshner, N. Opioid peptides in human adrenal medulla and
pheochromocytoma. In: "Degradation of Endogenous Opioids: Its Relevance in Human Pathology and Therapy." Ed.
S. Ehrenpreis and F. Sicuteri. Raven Press, New York, pp. 11-24, 1983.
8. Cubeddu, L.X. Calcium channel blockers as monotherapy in hypertension. In: "Current Status of Calcium Channel
Blockers in Hypertension". Ed. S.E. Epstein. Biomedical Information Corporation, pp. 65-83, 1986.
9. Cubeddu, L.X. Comparative effects of verapamil and propranolol in hypertension. In: "Hypertension - The Next
Decade". Ed. A. Fleckenstein and J.H. Laragh. Churchill Livingstone, pp. 101-105, 1987.
10. Cubeddu, L.X. Rate and duration of stimulation: As a determinant of drug action on the CNS. In Recent Advances
in Pharmacology and Therapeutics. Excerpta Medica., International Congress Series 839. Eds. M. Velasco, A. Israel,
E. Romero and H. Silva. Elsevier, Amsterdam, pp 307-313, 1989.
11. Cubeddu, L.X. and Kessler, J.M. Special Clinical Situations: Cardiovascular Therapy in Patients with Organ
Failure. Section III. In "Cardiovascular Drug Therapy". Ed. F.H.Messerli. Philadelphia, W.B.Saunders, 1990.
12. Cubeddu, L.X. Modulation of dopamine release from corpus striatum, limbic regions and prefrontal cortex by
presynaptic receptors. In "Presynaptic Regulation of Neurotransmitter Release; a Handbook". Ed. JJ Feigenbaum and
M Hannani, Freund Publishing House Ltd., London, England. In Press, 1990 (33 typed pages)
13. Cubeddu L.X., Hoffmann I.S. and Talmaciu R.K. Is the release of dopamine from medial prefrontal cortex
modulated by presynaptic receptors ? Comparison with nigrostriatal and mesolimbic terminals. In Presynaptic receptors
and the question of autoregulation of neurotransmitter release. Eds. Stanley Kalsner and Thomas Westfall. The New
York Academy of Sciences. vol 604; p 452-461, 1990.
14. Bonnet, J-J, Benmansour, S., Chab, N., Costentin, J., Parker, E.M. and Cubeddu, L.X. Ionic and temperature
dependence of the 3H-dopamine specific uptake and 3H-GBR 12783 or 3H-mazindol specific binding on the dopamine
neuronal carrier. Advances in the Biosciences. Presynaptic Receptors and Neuronal Transporters. Eds. Langer SZ.,
Galzin AM, and Costentin J. Pergamon Press, 1991; 189-192.
39